Magellan Health Valuation

MGLN -- USA Stock  

USD 61.87  0.20  0.32%

Magellan Health secures last-minute Real Value of $70.69 per share. The latest price of the firm is $61.87. At this time the firm appears to be undervalued. This module forecasts value of Magellan Health from analyzing the firm fundamentals such as Current Valuation of 2.17B, Profit Margin of 0.18% and Return On Equity of 1.00% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
September 20, 2019
Market Value
Real Value
Magellan Health is very steady asset. Calculation of real value of Magellan Health is based on 3 months time horizon. Increasing Magellan Health time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
Magellan Health Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    

Magellan Health Market Cap

Magellan Health is rated below average in market capitalization category among related companies. Market capitalization of Health Care Plans industry is now estimated at about 318.03 Billion. Magellan Health adds roughly 1.51 Billion in market capitalization claiming only tiny portion of equities under Health Care Plans industry.
Capitalization  Revenue  Valuation  Total debt  Workforce
Horizon     30 Days    Login   to change
Magellan Health is regarded fourth in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about  0.01  of Price to Book per Price to Earning. The ratio of Price to Earning to Price to Book for Magellan Health is roughly  99.45 

Valuation Basics

Magellan Health Enterprise Value Fundamentals

Quick Ratio1.08
Earnings Quarterly Growth0.50%
Revenue Growth-1.20%
Enterprise Value To Ebitda15.98
Earnings Growth5.70%
Enterprise Value To Revenue0.30

Valuation Indicators

Magellan Health Valuation Fundamental Ratios

Please see also Stocks Correlation. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.